The proteasome inhibitor bortezomib inhibits the release of NF kappa B-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients

J.W. van der Heijden, R. Oerlemans, W.F. Lems, R.J. Scheper, B.A.C. Dijkmans, G. Jansen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)92-98
JournalClinical and Experimental Rheumatology
Issue number1
Publication statusPublished - 2009

Cite this